Vitamin D Deficiency Treatment and Prevention Protocol
Primary Stack
Core supplements with strongest evidencePrimary treatment for deficiency; D3 is more effective than D2 at raising blood levels
Works synergistically with vitamin D; directs calcium to bones rather than arteries
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsRequired for vitamin D activation and metabolism; deficiency impairs vitamin D function
Supporting Studies (1)
Vitamin D enhances calcium absorption; adequate calcium needed for bone health
Supporting Studies (1)
Supports vitamin D receptor function; often co-deficient with vitamin D
Supporting Studies (1)
Works with vitamin D in immune function and bone health; balance is important
Supporting Studies (1)
May enhance vitamin D effectiveness and support calcium metabolism
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Vitamin D deficiency is extremely common, affecting an estimated 1 billion people worldwide. Vitamin D is unique because it functions as a hormone and affects virtually every cell in the body. It's essential for bone health, immune function, mood, and many other processes.
VITAMIN D LEVELS:
RISK FACTORS for deficiency:
SYMPTOMS of deficiency:
TREATMENT APPROACH:
1. Test 25-OH vitamin D level
2. Treat deficiency with loading dose if severe
3. Maintain with daily or weekly supplementation
4. Retest after 8-12 weeks
DOSING GUIDELINES:
* Vitamin D3 (cholecalciferol) is preferred over D2 as it raises blood levels more effectively.
* Vitamin K2 helps direct calcium to bones and away from arteries.
* Magnesium is required for vitamin D activation.
Expected timeline: Blood levels typically take 6-8 weeks to significantly improve. Symptoms may improve sooner.
Clinical Perspective
Vitamin D Deficiency: 25-OH vitamin D <20 ng/mL. Prevalence: ~40% US adults, higher in elderly, obese, dark-skinned, institutionalized. Functions: calcium homeostasis, bone health, immune modulation, cell differentiation. Consequences: rickets (children), osteomalacia, osteoporosis risk, muscle weakness, possible associations with cancer, cardiovascular disease, autoimmune disease, infections. Testing: 25-OH vitamin D (not 1,25-OH which is regulated and can be normal in deficiency).
CRITICAL: Test before treating; retest after 8-12 weeks. Endocrine Society guidelines: deficient <20 ng/mL, insufficient 20-29, sufficient >=30. D3 preferred over D2. Treat with repletion dose then maintenance. Consider causes (malabsorption, medications). Monitor for hypercalcemia with high doses. Take with fat for absorption.
* Vitamin D3 (A-grade): Primary treatment. Guidelines: (PMID: 28750270). Meta-analysis D3 vs D2: (PMID: 26096827). Dosing: Maintenance 1000-2000 IU; insufficiency 2000-4000 IU; deficiency 50,000 IU/week x 6-8 weeks then maintenance.
* Vitamin K2 (B-grade): Calcium direction; synergy. Meta-analysis: (PMID: 28747906). 100-200mcg MK-7 daily.
* Magnesium (B-grade): Required for D activation. Systematic review: (PMID: 28150472). 300-400mg daily.
* Calcium (B-grade): D enhances absorption. Meta-analysis: (PMID: 26443622). 500-1000mg if dietary intake low.
* Zinc (C-grade): VDR function. Review: (PMID: 26845419). 15-30mg daily.
* Vitamin A (C-grade): Interactions. Review: (PMID: 27450775). 2500-5000 IU daily. Balance important.
* Boron (C-grade): D metabolism. Review: (PMID: 25758370). 3-6mg daily.
Assessment targets: 25-OH vitamin D level, calcium, PTH, renal function before high-dose treatment.
Protocol notes: D3 vs D2: D3 raises levels more effectively; D2 acceptable if vegetarian. Absorption: take with fat-containing meal; 20% absorption difference. Loading doses: 50,000 IU/week x 6-8 weeks common for deficiency. High-risk patients: malabsorption (celiac, gastric bypass), anticonvulsants, glucocorticoids may need higher doses. Toxicity: rare but possible; hypercalcemia, hypercalciuria symptoms; levels >100 ng/mL concerning. PTH: secondary hyperparathyroidism with D deficiency; normalize PTH goal. Bone health: D + calcium for osteoporosis prevention; weight-bearing exercise. Sun exposure: 15-30 min midday sun, skin type dependent; often insufficient especially in winter/high latitudes. Obesity: D sequestered in fat; may need higher doses. Kidney disease: may need active D (calcitriol); nephrology guidance. Maintenance: ongoing supplementation needed; levels drop without continued intake. Timing: morning or with largest meal; half-life ~2-3 weeks so daily or weekly dosing equivalent.